FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to ophthalmology, and can be used to predict the survival capacity of patients after enucleation for initial choroid melanoma spread to the optic disc. The method includes determining the degree of accumulation of myeloid suppressor cells in the micro-environment of melanoma. If 2 degree accumulation thereof is detected, survival capacity from 5 to 7 months is predicted.
EFFECT: possibility of determining the survival period of patients after enucleation for initial choroid melanoma spread to the optic disc, in order to select the corresponding strategy for the postoperative management of patients.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF UVEAL MELANOMA ASSOCIATED WITH A MALIGNANT MICROENVIRONMENT | 2019 |
|
RU2709214C1 |
| METHOD FOR PREDICTION OF SEVERE UVEAL MELANOMA | 2019 |
|
RU2705417C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF INITIAL CHOROID MELANOMA AFTER ORGAN-PRESERVING TREATMENT, BASED ON DETERMINATION OF LEVEL OF TRANSFORMING GROWTH FACTOR TGF-β2 | 2020 |
|
RU2733577C1 |
| METHOD FOR PREDICTION OF SURVIVAL RATE AFTER ENUCLEATION WITH UVEAL MELANOMA DEVELOPED TO EQUATOR | 2024 |
|
RU2822319C1 |
| METHOD FOR DETECTING AN INFLAMMATORY COMPONENT THAT PROMOTES TUMOR GROWTH IN INITIAL CHOROIDAL MELANOMA | 2020 |
|
RU2748528C1 |
| METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53 | 2002 |
|
RU2208789C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER Bax | 2002 |
|
RU2208790C1 |
| METHOD FOR ULTRASOUND DIAGNOSIS OF INVASION OF JUXTAPAPILLARY UVEAL MELANOMA (UM) INTO THE INTRABULBAR PART OF THE OPTIC NERVE | 2023 |
|
RU2807527C1 |
| METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 1999 |
|
RU2157998C1 |
